Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Biomedical Science|April 16, 2024
Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's diseaseTamara Vasilkovska, Somaie Salajeghe, Verdi Vanreusel, et al.Current Biology : CB|April 24, 2018
Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the MidbrainJennifer M Wenzel, Erik B Oleson, Willard N Gove, et al.Molecular Psychiatry|August 18, 2018
Activation of the mGlu<sub>1</sub> metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M<sub>4</sub> muscarinic receptor allosteric modulatorsSamantha E Yohn, Daniel J Foster, Dan P Covey, et al.Cell Reports|March 24, 2026
Endocannabinoid modulation of a reciprocal fronto-coerulear connection in contextual discriminationAndrea Locarno, Luca Nava, Noemi Barsotti, et al.Nature Neuroscience|December 30, 2025
Distinct endocannabinoids specifically signal to astrocytes or neurons in the adult mouse hippocampusJose Antonio Noriega-Prieto, Rafael Falcón-Moya, Jacob A Noeker, et al.Elife|November 29, 2018
Rat behavior and dopamine release are modulated by conspecific distressNina T Lichtenberg, Brian Lee, Vadim Kashtelyan, et al.Journal of Medicinal Chemistry|July 11, 2022
Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's DiseaseTammy Ladduwahetty, Matthew R Lee, Michel C Maillard, et al.Neuron|December 27, 2011
Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neuronsMichelle S Mazei-Robison, Ja Wook Koo, Allyson K Friedman, et al.Journal of Medicinal Chemistry|March 30, 2021
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's DiseaseAmanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, et al.Journal of Medicinal Chemistry|March 7, 2019
Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease ModelsLeticia Toledo-Sherman, Perla Breccia, Roger Cachope, et al.Pageof 11